Newsfeeds Archive - Spark Newswire

4 minute read

Paratek Pharmaceuticals Files Definitive Proxy Statement And Letter To Stockholders In Connection With Acquisition By Gurnet Point Capital And Novo Holdings

August 2, 5:41 PM

Transaction Provides Paratek Stockholders with Immediate Value and Liquidity Stockholders to Receive Upfront Cash Payment of $2.15 per Share and a Contingent Value Right of $0.85 per Share on

PRTK

2 minute read

Paratek Pharmaceuticals Announces Modification Of BARDA Contract To Advance The Development Of NUZYRA For Post-Exposure Prophylaxis And Treatment Of Pulmonary Anthrax

By Happy Mohamed

July 10, 8:04 AM

-- Third procurement to be split into two procurements based on the achievement of specific anthrax development milestones -- Next procurement expected in early 2024 BOSTON, July 10, 2023 (GLOBE NEWSWIRE)

PRTK

1 minute read

Paratek Pharmaceuticals Acknowledges Receipt Of NexPoint Letter; Says Co’s Board Of Directors Respectfully Disagrees With NexPoint’s Characterizations Contained In Its Letter

By Happy Mohamed

June 27, 12:04 PM

Paratek Pharmaceuticals, Inc. ("Paratek") (NASDAQ:PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel therapies for life-threatening diseases and

PRTK

7 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For June 7, 2023

By Benzinga Insights

June 7, 11:00 AM

Upgrades According to Janney Montgomery Scott, the prior rating for Consolidated Water Co Ltd (NASDAQ:CWCO) was changed from…

AMED

1 minute read

Why Paratek Pharmaceuticals Stock Is Up Today

By Ryan Gustafson

June 6, 3:38 PM

Shares of Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK), a commercial-stage biopharmaceutical company, are up Tuesday after the company announced that it entered into a definitive agreement to be acquired by Gurnet Point Capital and Novo

PRTK

1 minute read

Paratek Pharmaceuticals Agrees To Be Taken Private By Gurnet Point And Novo Holdings For $462M

By Akanksha Bakshi

June 6, 12:42 PM

Paratek Pharmaceuticals, Inc (NASDAQ:PRTK) has agreed to be acquired by Gurnet Point Capital and Novo Holdings A/S in a transaction valued…

PRTK

1 minute read

Earnings

Recap: Paratek Pharmaceuticals Q1 Earnings

By Benzinga Insights

May 9, 4:15 PM

Paratek Pharmaceuticals (NASDAQ:PRTK) reported its Q1 earnings results on Tuesday, May 9, 2023 at 04:05 PM. Here’s what…

PRTK

29 minute read

Earnings

Earnings Scheduled For May 9, 2023

By Benzinga Insights

May 9, 6:03 AM

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.17 per share on revenue of $440.16 million.

ABNB